Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax
Alexander Waclawiczek(German Cancer Research Center), Andreas Trumpp(German Cancer Research Center)
Cited by 94
Related Papers
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
|Nature Cancer|2022|224
Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia
|Journal of Clinical Investigation|2020|104
Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1
|Blood|2022|100
Niche derived netrin-1 regulates hematopoietic stem cell dormancy via its receptor neogenin-1
|Nature Communications|2021|85